Johnson & Johnson (JNJ.N)
23 Feb 2018
A federal judge has ruled that the U.S. Food and Drug Administration acted reasonably when it declined last year to grant Amgen Inc a six-month period of marketing exclusivity for pediatric uses of its kidney drug Sensipar.
* JOHNSON & JOHNSON MEDICAL DEVICES COMPANIES ACQUIRE ORTHOTAXY TO DEVELOP NEXT-GENERATION ROBOTIC-ASSISTED SURGERY PLATFORM IN ORTHOPAEDICS
The U.S. Food and Drug Administration on Wednesday approved Johnson & Johnson's Erleada for use in prostate cancer patients whose disease has not spread but continues to grow despite hormone therapy.
Feb 14 The U.S. Food and Drug Administration on Wednesday approved Johnson & Johnson's Erleada for use in prostate cancer patients whose disease has not spread but continues to grow despite hormone therapy.
Feb 14 The U.S. Food and Drug Administration on Wednesday approved Johnson & Johnson's Erleada treatment for use with prostate cancer patients whose cancer has not spread but continues to grow despite hormone therapy.
Drugmaker AbbVie Inc significantly boosted its 2018 earnings forecast on Friday with help from U.S. tax reform and said it hopes to accelerate dividend growth and share buybacks, sending its stock soaring to an all-time high.
A New Jersey state court judge on Monday delayed the start of a trial by a man who said he developed mesothelioma from being exposed to Johnson & Johnson's talc products after reversing a previous ruling that had barred a defense expert from testifying.
NEW YORK U.S. stocks advanced on Tuesday, as strong results from Netflix helped lift the S&P and Nasdaq Composite, but the Dow Industrials were hemmed in by declines in Johnson & Johnson and Procter & Gamble. | Video
Jan 23 The following bids, mergers, acquisitions and disposals were reported by 2030 GMT on Tuesday:
* Dow down 0.07 pct, S&P 500 up 0.15 pct, Nasdaq up 0.56 pct (Updates to mid-afternoon, changes byline)
|General Electric Company (GE.N)||$14.49||-0.13|
|Procter & Gamble Co (PG.N)||$81.05||+0.21|
|Pfizer Inc. (PFE.N)||$36.26||+0.52|
|Novartis AG (NOVN.S)||CHF79.38||-0.60|
|Merck & Co., Inc. (MRK.N)||$54.87||+0.30|
|Baxter International Inc (BAX.N)||$68.36||+0.93|
|Stryker Corporation (SYK.N)||$161.70||+2.74|
|Boston Scientific Corporation (BSX.N)||$27.20||+0.72|
|Zimmer Biomet Holdings Inc (ZBH.N)||$118.85||+1.27|